Artificial Intelligence in Patient Education for Androgenetic Alopecia: A Comparative Study of ChatGPT, Gemini, and Deepseek R1

October 2025 in “ Dermatology Practical & Conceptual ”

Seçil Yigen İritaş

TLDR ChatGPT 4.0 and Gemini 1.5 Flash are effective for educating patients about androgenetic alopecia, while Deepseek R1 is less reliable.

The study compared the effectiveness of ChatGPT 4.0, Gemini 1.5 Flash, and Deepseek R1 in educating patients about androgenetic alopecia (AGA). ChatGPT 4.0 and Gemini 1.5 Flash answered all 12 patient questions accurately and were rated as satisfactory with minimal corrections, while Deepseek R1 only answered five questions and often provided inaccurate information. Gemini 1.5 Flash enhanced interpretability with visual aids and citations. All models produced responses at a high school reading level, but ChatGPT 4.0 and Gemini 1.5 Flash offered a better user experience. The study concludes that ChatGPT 4.0 and Gemini 1.5 Flash are effective tools for patient education on AGA, whereas Deepseek R1's inaccuracies necessitate careful use.

View this study on dpcj.org →

Discuss this study in the Community →

Research cited in this study

10 / 10 results

Recommendations on the Clinical Management of Androgenetic Alopecia: A Consensus Document from the Spanish Group of Trichology of the Spanish Academy of Dermatology and Venereology

research Recommendations on the Clinical Management of Androgenetic Alopecia: A Consensus Document from the Spanish Group of Trichology of the Spanish Academy of Dermatology and Venereology

February 2024 in “Actas Dermo-Sifiliográficas”

Dermatologists recommend oral dutasteride for male hair loss, low-dose oral minoxidil for female hair loss, and a multidisciplinary approach for young patients, with caution during pregnancy.

research A Machine Learning Algorithm Applied to Trichoscopy for Androgenic Alopecia Staging and Severity Assessment

July 2023 in “Dermatology practical & conceptual”

The machine learning model effectively assesses the severity of hair loss and could help dermatologists with treatment decisions.

research Efficacy and Safety of Topical Finasteride Spray Solution for Male Androgenetic Alopecia: A Phase III, Randomized, Controlled Clinical Trial

11 citations , October 2021 in “Journal of The European Academy of Dermatology and Venereology”

Topical finasteride is an effective and safer treatment for male hair loss.

research Androgenetic Alopecia in Women and Men: Italian Guidelines Adapted from European Dermatology Forum/European Academy of Dermatology and Venereology Guidelines

4 citations , December 2020 in “Giornale italiano di dermatologia e venereologia”

Italian guidelines recommend using trichoscopy for diagnosis and treatments like minoxidil for hair loss.

research Fibrosing Alopecia in a Pattern Distribution

30 citations , January 2020 in “Journal of The American Academy of Dermatology”

Fibrosing alopecia in a pattern distribution is a hair loss condition often confused with other types, requiring early treatment but usually not resulting in significant hair regrowth.

research Platelet-Rich Plasma as a Treatment for Androgenetic Alopecia

39 citations , March 2019 in “Dermatologic Surgery”

PRP therapy increases hair density for androgenetic alopecia.

research Evidence-Based Guideline for the Treatment of Androgenetic Alopecia in Women and Men – Short Version

145 citations , November 2017 in “Journal of The European Academy of Dermatology and Venereology”

Use minoxidil for hair loss treatment; assess results after 6 months.

research Frontal Fibrosing Alopecia in Men: Presentation of 12 Cases and Literature Review

26 citations , August 2016 in “Actas Dermo-Sifiliográficas”

Frontal Fibrosing Alopecia in men is often missed and can come with symptoms like facial bumps and hair loss on eyebrows and limbs.

research Male Androgenetic Alopecia

3 citations , March 2014 in “Turkderm”

Hair loss in men can be slowed or reversed with treatments like minoxidil and finasteride, but it resumes if treatment stops. It may also indicate early heart disease and obesity.

research Postmenopausal Frontal Fibrosing Alopecia: A Frontal Variant of Lichen Planopilaris

329 citations , January 1997 in “Journal of the American Academy of Dermatology”

Frontal fibrosing alopecia is a hair loss condition in postmenopausal women, similar to lichen planopilaris, with ineffective treatments.

Related Community Posts Join

6 / 1000+ results

community Proposed new pathogenesis model for androgenetic alopecia (AGA)

in Research/Science 7 upvotes 2 years ago

The conversation discusses a new model for understanding androgenetic alopecia (AGA), linking it to dietary and lifestyle factors similar to PCOS, and highlighting the role of DHT, vascular damage, and inflammation. Treatments mentioned include Minoxidil, finasteride, and RU58841.

community The Effect of Intradermal Botox on Androgenetic Alopecia and Its Possible Mechanism (Journal of the American Academy of Dermatology (2020)

in Treatment 12 upvotes 5 years ago

Intradermal botulinum toxin (BTX) injections effectively treat androgenetic alopecia (AGA) by inhibiting TGF-β1 secretion from hair follicles. Further research and long-term follow-up are needed to confirm these findings.

community Eliminate/Confirm AGA based on blood report

in General 126 upvotes 3 months ago

A 19-year-old male with no family history of androgenetic alopecia (AGA) is experiencing hair loss and considering using a topical minoxidil and finasteride mixture. Despite low vitamin D levels and normal DHT serum levels, he seeks confirmation of AGA before starting treatment.

community Spanish dermatologist suggests sulforaphane for AGA

in Research/Science 13 upvotes 1 year ago

A Spanish dermatologist suggests sulforaphane for androgenetic alopecia (AGA) due to its potential to remove DHT metabolites, though high dosages are needed. A topical formulation might be possible.

community What do you think will be the next "big innovation" regarding AGA?

in Research/Science 10 upvotes 1 year ago

The conversation discusses potential new treatments for androgenetic alopecia (AGA), including verteporfin, pyrilutamide, and hair cloning. There is optimism about scientific advancements providing alternatives to minoxidil and finasteride.

Compressed part of research of theory of androgenic/anabolitic balance. AGA h-responders analytic. Theory of physio-metabolitic method of anti AGA treatment

community Compressed part of research of theory of androgenic/anabolitic balance. AGA h-responders analytic. Theory of physio-metabolitic method of anti AGA treatment

in Research 865 upvotes 11 months ago

The treatment for androgenetic alopecia involves using finasteride and minoxidil with intense exercise and cold exposure to boost metabolism and reduce androgenic effects, potentially leading to hair regrowth. This approach may activate biological pathways for improved hair and overall health.

Similar Research

6 / 1000+ results

An Uncontrolled Case Series Testing Cryo-Chilled Carbon Dioxide as a Novel Amplification of a Nano-Botanical Multi-Acting Therapy in Advanced Stage Androgenetic Alopecia

research An Uncontrolled Case Series Testing Cryo-Chilled Carbon Dioxide as a Novel Amplification of a Nano-Botanical Multi-Acting Therapy in Advanced Stage Androgenetic Alopecia

January 2025

The treatment showed promising results in improving advanced-stage hair loss.

research 52243 AH-001: An Emerging Androgen Receptor Degrader Showing Therapeutic Potential in Addressing Androgenetic Alopecia

September 2024 in “Journal of the American Academy of Dermatology”

AH-001 could be a safer and more effective treatment for hair loss.

The Comparison of Metabolic Syndrome Parameters, Trichoscopic and Trichoscan Characteristics in Androgenetic Alopecia (AGA) and Early-Onset Androgenetic Alopecia (Early-Onset AGA)

research The Comparison of Metabolic Syndrome Parameters, Trichoscopic and Trichoscan Characteristics in Androgenetic Alopecia (AGA) and Early-Onset Androgenetic Alopecia (Early-Onset AGA)

August 2024 in “Archives of Dermatological Research”

Androgenetic alopecia may be linked to metabolic syndrome.

Assessing Low-Dose Oral Minoxidil Efficacy in Androgenetic Alopecia: A Comparative Study of AGA and AGA Unmasked by Telogen Effluvium

research Assessing Low-Dose Oral Minoxidil Efficacy in Androgenetic Alopecia: A Comparative Study of AGA and AGA Unmasked by Telogen Effluvium

August 2024 in “Archives of Dermatological Research”

Low-dose oral minoxidil is effective and safe for treating androgenetic alopecia.

Comparison of Metabolic Syndrome Parameters, Trichoscopic and Trichoscan Characteristics in Androgenetic Alopecia and Early-Onset Androgenetic Alopecia

research Comparison of Metabolic Syndrome Parameters, Trichoscopic and Trichoscan Characteristics in Androgenetic Alopecia and Early-Onset Androgenetic Alopecia

June 2024 in “Research Square (Research Square)”

Early-onset AGA shows different hair and metabolic characteristics compared to normal-onset AGA.

research Androgenetic Alopecia

January 2018

Androgenetic alopecia (AGA) is a common, hereditary hair loss condition that can be slowed but not permanently reversed with available therapies.